The study, titled Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned? examined data from people who were on GLP-1 drugs for 1 to 3 years
It is also an option for adults with a BMI of 27 kg/m or higher if they have at least one weight-related health problem like type 2 diabetes, high blood pressure, or high cholesterol
A little background: In May 2025, Novo Nordisk, the maker of Rybelsus, Wegovy, and Ozempic, applied for FDA approval of an oral version of Wegovy
During treatment with LUMIGAN 0.01%, you may experience certain changes in your eye such as sunken eyes, eyelid drooping, skin tightening around the eyes, sudden growth in eyelashes or darkness around the eyes or in the iris